Annual report pursuant to Section 13 and 15(d)

Intangible Assets (Details Narrative)

v3.19.1
Intangible Assets (Details Narrative) - USD ($)
12 Months Ended
Mar. 19, 2018
Oct. 04, 2017
Oct. 04, 2017
Dec. 31, 2018
Dec. 31, 2017
Purchase of software license       $ (20,500)
Capitalized cost       3,037,147  
Purchase price       8,000,000  
Business combination of tax basis       $ 1,782  
Number of shares acquired in exchange for common stock   31,745,242   2,090,301  
Common stock shares issued       38,674,265 35,272,626
Common stock shares outstanding       38,674,265 35,272,626
Licence agreement description       The negotiation of the modification to the Agreement was in process as of October 4, 2017 and was finalized in mid-February 2018 and the legal documents were thereafter executed and the option was exercised on March 19, 2018 in exchange for CoNCERT receiving: (i) $8 million of our common stock that was held by Promet LLC for the benefit of CoNCERT; (ii) royalties, on a product-by-product basis, on worldwide net sales of products during each year as follows: (a) four percent (4%) of sales less than or equal to $100 million; (b) five percent (5%) of sales greater than $100 million and less than or equal to $500 million; (c) six percent (6%) of sales greater than $500 million and less than or equal to $1 billion; and, (d) for that portion greater than $1 billion, (i) with respect to net sales made by Promet or any of its affiliates, ten percent (10%) of net sales, and (ii) with respect to net sales made by any sub-licensee, the greater of (1) 6% of such net sales or (2) 50% of all payments received by Promet or any of its affiliates with respect to such net sales; and (iii) 15% of any sublicense revenue earned by us for a period equivalent to the royalty term (as defined in the Agreement) until the earliest of (a) our raising $8 million of gross proceeds  
Proceeds from common stock       $ 2,874,687
Amortization expense       $ 621,647
Weighted average amortization period for intangible asset       2 years  
Future amortization expense, year two       $ 795,000  
Future amortization expense,thereafter       788,000  
Agreement [Member]          
Sublicence agreement percentage   15.00% 15.00%    
Catagory 1 [Member] | Sub-licensee [Member]          
Percentage of sales percentage   6.00% 6.00%    
CoNCERT Pharmaceuticals, Inc [Member]          
Capitalized cost       11,038,929  
Transaction costs       $ 1,782  
Option exercised in exchange for common stock $ 8,000,000        
Number of shares acquired in exchange for common stock 2,090,301        
Shares acquired price per share $ 3.83        
Common stock shares issued 35,272,626        
Common stock shares outstanding 35,272,626        
Percentage of controlling interest 6.00%        
Fair value of intangible assets $ 8,000,000        
Proceeds from royalty receivable     $ 8,000,000    
Proceeds from common stock $ 8,000,000        
CoNCERT Pharmaceuticals, Inc [Member] | Catagory 1 [Member]          
Percentage of sales percentage   4.00% 4.00%    
CoNCERT Pharmaceuticals, Inc [Member] | Catagory 1 [Member] | Maximum [Member]          
Amount of sales limit     $ 100,000,000    
CoNCERT Pharmaceuticals, Inc [Member] | Catagory 2 [Member]          
Percentage of sales percentage   5.00% 5.00%    
CoNCERT Pharmaceuticals, Inc [Member] | Catagory 2 [Member] | Maximum [Member]          
Amount of sales limit     $ 500,000,000    
CoNCERT Pharmaceuticals, Inc [Member] | Catagory 2 [Member] | Minimum [Member]          
Amount of sales limit     $ 100,000,000    
CoNCERT Pharmaceuticals, Inc [Member] | Catagory 3 [Member]          
Percentage of sales percentage   6.00% 6.00%    
CoNCERT Pharmaceuticals, Inc [Member] | Catagory 3 [Member] | Maximum [Member]          
Amount of sales limit     $ 1,000,000,000    
CoNCERT Pharmaceuticals, Inc [Member] | Catagory 3 [Member] | Minimum [Member]          
Amount of sales limit     500,000,000    
CoNCERT Pharmaceuticals, Inc [Member] | Catagory 4 [Member] | Minimum [Member]          
Amount of sales limit     $ 1,000,000,000    
Promet/Heatwurx [Member]          
Acquition percentage 6.00%        
Promet [Member]          
Percentage of controlling interest 84.00%        
Promet [Member] | Catagory 1 [Member]          
Percentage of sales percentage   10.00% 10.00%    
Promet [Member] | Catagory 2 [Member]          
Percentage of sales percentage   50.00% 50.00%